关键信息
-
基因名
CGb1
- 应用
-
别名
CG-B1; Choriogonadotropin Subunit Beta Variant 1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A6NKQ9
-
表达区间
Tyr55~Pro153
-
分子量
14kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
CGb1 recombinant protein, derived from the Chlamydia genus, has garnered significant attention in recent years due to its critical role in understanding chlamydial pathogenesis and the immune response it elicits. Chlamydia is a leading cause of sexually transmitted infections worldwide and can lead to severe reproductive health issues, including infertility. The protein CGb1, identified as a potential immunogenic target, is believed to participate in the modulation of host immune responses during infection. Research suggests that CGb1 may play a role in the bacteria's ability to evade immune detection, making it a crucial molecule for further study. By characterizing CGb1, scientists aim to elucidate its functional mechanisms and its interactions with host cells, which could pave the way for the development of novel therapeutic interventions and vaccines against chlamydial infections. Moreover, understanding its structure and function could lead to insights into the broader category of microbial pathogenesis. With the increasing incidence of chlamydial infections and the growing demand for effective prevention strategies, CGb1 recombinant protein research represents a pivotal area of investigation in microbiology and immunology, highlighting the need for innovative approaches to combat this public health challenge.
